MedVi vs Regenics: Semaglutide and Care Compared
MedVi vs Regenics is a direct comparison for patients who want cash-pay, telehealth access to compounded GLP-1 therapy. Early verdict: choose MedVi if you prioritize 24/7 certified medical support and a no-clinic pathway; choose Regenics if you want lower first-month semaglutide pricing or access to tirzepatide.
Head-to-head: price and promotional structure
Price is one of the clearest differences in this comparison. MedVi advertises a winter promotional first month starting at $179 with fast, free shipping, but notes the ongoing standalone month price rises to $299 and a three-month plan is $649. Regenics lists semaglutide at $139 for the first month with renewal at $199, and tirzepatide at $189 first month with renewal at $279. Both platforms use promotional first-month pricing that increases on renewal.
See Regenics first-month pricing
Medications offered: semaglutide only versus multiple GLP-1 options
MedVi offers compounded semaglutide only. Regenics offers both compounded semaglutide and compounded tirzepatide, plus an optional Sermorelin peptide. If access to tirzepatide is important, Regenics documents a tirzepatide option starting at $189 for the first month. MedVi does not offer tirzepatide and states it provides semaglutide only.
Check MedVi’s semaglutide program
Clinical oversight and support model
Both platforms deliver care through telehealth but describe different clinician models. MedVi highlights 24/7 support from certified medical professionals and an online intake with clinician review; it names OpenLoop Health clinicians as part of the process and says a licensed clinician will determine eligibility. Regenics states licensed nurse practitioners review intake and oversee prescriptions. The difference is MedVi emphasizes around-the-clock certified medical support while Regenics emphasizes nurse-practitioner-led oversight and a pharmacy network certified by LegitScript.
Compounded medication, shipping, and regulatory notes
Both MedVi and Regenics offer compounded medications prepared by U.S. compounding pharmacies and both include free shipping in their promotional materials. Each provider explicitly notes that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality. MedVi adds detail about its partnerships with multiple USA certified pharmacies and that medication is shipped directly to patients after clinician review. Regenics notes its pharmacy network is LegitScript certified.
Five key differences table
| Criteria | MedVi | Regenics |
|---|---|---|
| Starting first-month price | $179 first month | $139 semaglutide; $189 tirzepatide first month |
| Ongoing renewal pricing | Standalone month $299; three-month plan $649 | Semaglutide renews $199; tirzepatide renews $279 |
| Medications available | Compounded semaglutide only | Compounded semaglutide and tirzepatide; Sermorelin available |
| Clinical model | 24/7 certified medical support, clinician review via OpenLoop Health | Licensed nurse practitioners review intake and oversee prescriptions |
| Pharmacy and regulation notes | Compounded meds; partnered with multiple USA certified pharmacies; not FDA-approved finished products | Compounded meds from U.S. pharmacies; LegitScript certified network; not FDA-approved finished products |
Outcomes, guarantees, and what is not supplied
MedVi cites self-reported patient data and claims typical patient weight changes on its platform, while also noting results vary and that compounded medications are not FDA-approved. Regenics does not publish outcome statistics on the captured page. Neither provider supplies a formal, published weight-loss guarantee in the supplied evidence. If specific efficacy numbers or long term outcomes are critical to you, Regenics does not provide outcomes on the captured page and MedVi reports self-reported averages with clear caveats.
Explore Regenics medication options
How to choose between MedVi and Regenics
Choose MedVi if you want a no-clinic, online-first pathway with 24/7 certified medical support and a promotional first month at $179, understanding the ongoing standalone month price rises to $299 and that MedVi offers compounded semaglutide only. Choose Regenics if you prioritize the lowest first-month semaglutide price at $139, want access to compounded tirzepatide starting at $189 first month, or value a LegitScript certified pharmacy network with nurse-practitioner-led oversight.
Start MedVi if you want 24/7 support
Both providers require a licensed clinician to determine medical appropriateness, both operate as cash-pay telehealth models, and both emphasize that compounded medications are not FDA-approved finished products. Use the pricing, medication choice, and clinician model differences above to match the platform to your priorities when evaluating MedVi vs Regenics.